Late Breaking News
SAN FRANCISCO - The FDA has approved Kadcyla (ado-trastuzumab emtansine or T-DM1) for the treatment of people with HER2-positive metastatic breast cancer (mBC) who have received prior treatment with Herceptin (trastuzumab) and a taxane chemotherapy.
TRAVIS AIR FORCE BASE, CA — The Air Force had good timing for its survey of energy drink consumption within the service: The Substance Abuse and Mental Health Services Administration (SAMHSA) recently released a new report showing a doubling of energy drink-related emergency department (ED) visits between 2007 and 2011.
FORT DETRICK, MD - Far from expiring in the one to five years stated on their labels, many prescription medications may retain their full potency for 10, 20, even 40 years.
CHICAGO — A government report shows that delays in integrating VA and DoD IT systems at the James A. Lovell Federal Health Care Center (FHCC) in Chicago have proven costly for the jointly-run facility. VA officials responded, however, that lessons learned during this process may prove helpful in the attempt to integrate systems on a national level.
DURHAM, NC — Research into investigational drugs focuses on clinical safety and effectiveness after use and must assume that the correct drug was administered in the correct dose.
INDIANAPOLIS, IN — While the medication alerts, automated reminders and warnings that pop up in electronic medical records (EMRs) improve patient care in theory, reality can be quite different: Alerts may be viewed as unhelpful noise by providers and rarely lead to medication changes.
WASHINGTON — Veterans with PTSD are more likely than others to be prescribed opioids for post-injury pain, and that can lead to an increase in adverse mental and physical effects, according to a recent VA study.
WASHINGTON — Scope of practice for pharmacists in the private sector needs to be expanded to improve the quality and costs of healthcare delivery, according to a new U.S. Public Health Service report.
WASHINGTON — As government agencies struggle with an ever-increasing number of drug shortages on a national level, pharmacists at VA hospitals deal with the problem — usually very successfully — on a day-to-day basis.
The survival rate for older men receiving colon cancer care and some types of lung cancer in VA was better than similar fee-for-service (FFS) Medicare beneficiaries, according to a study out of Harvard Medical School. 1
Most Popular Stories
- Many Healthcare Providers Lose VA Retention Bonuses
- Federal Medicine Organizational Meetings — Tarred with the Same Brush?
- Despite Formulary, High-Cost Diabetes Drug Use Varies Widely Across VA Facilities
- Report Says Administration Faces Hard Choices For Veterans Programs
- Physician Overcomes TBI to Return to Active-Duty Medicine
Join Our E-Mail List